Does CPAP Treatment Reduce Depression in OSA?
Research type
Research Study
Full title
Does CPAP treatment reduce depression and improve quality of life in patients diagnosed with obstructive sleep apnoea?
IRAS ID
237336
Contact name
Martyn Bucknall
Contact email
Sponsor organisation
St George's, University of London
Duration of Study in the UK
0 years, 6 months, 27 days
Research summary
Obstructive sleep apnoea (OSA) is a sleeping disorder brought about by the collapse of an individual's airways during sleep. The collapse of the airway starves the individual of oxygen causing them to wake up. As a result, the individual doesn't get a good night sleep and feels fatigued throughout the day. Daytime fatigue has been known to reduce someone's quality of life which could lead to depression. CPAP (Continuous positive airway pressure) is commonly used to treat OSA, this machine prevents the airways from collapsing during sleep. My aim is to investigate CPAP treatment and its effect on depression and quality of life in patients with OSA.
REC name
London - City & East Research Ethics Committee
REC reference
18/LO/0109
Date of REC Opinion
17 Jan 2018
REC opinion
Favourable Opinion